Who owns TAKEDA PHARMACEUTICAL CO LTD (TAK)? Elite investor 13F holders
5 tracked elite investors reported holding TAKEDA PHARMACEUTICAL CO LTD as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Tudor Investment, Pzena Investment Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive,…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 41165040.00 USD | 2568000.000000 | Shares | reduce | Original filing |
| D.E. Shaw | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 32852956.00 USD | 2049467.000000 | Shares | reduce | Original filing |
| Tudor Investment | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1605388.00 USD | 100149.000000 | Shares | buy | Original filing |
| Pzena Investment Management | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 606253.00 USD | 37820.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | TAKEDA PHARMACEUTICAL CO LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 22646.00 USD | 1413.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.